logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Hypothyroidism

    FiltersReset Filters
    7 results
    • euthyrox

      (levothyroxine sodium)
      Provell Pharmaceuticals, LLC
      Usage: EUTHYROX is indicated for thyroid hormone replacement therapy in primary, secondary, and tertiary hypothyroidism in both pediatric and adult patients. It is also used to suppress pituitary TSH in managing well-differentiated thyroid cancer during surgery and radioiodine therapy. Not for benign nodules or subacute thyroiditis recovery.
    • levo-t

      (Levothyroxine Sodium)
      Neolpharma Inc
      Usage: LEVO-T is indicated for replacement therapy in congenital or acquired hypothyroidism and for pituitary thyrotropin suppression in managing well-differentiated thyroid cancer. It is not recommended for benign thyroid nodules or during subacute thyroiditis recovery.
    • levothyroxine sodium

      (Levothyroxine Sodium)
      Accord Healthcare Inc.
      Usage: Levothyroxine sodium tablets are indicated for replacement therapy in congenital or acquired hypothyroidism in adults and children, including neonates. They are also used as an adjunctive treatment for suppressing TSH in well-differentiated thyroid cancer but not for benign nodules or recovery from subacute thyroiditis.
    • liothyronine sodium

      (liothyronine sodium)
      Sun Pharmaceutical Industries, Inc.
      Usage: Liothyronine sodium tablets are indicated for replacement therapy in congenital or acquired hypothyroidism, as an adjunct in managing well-differentiated thyroid cancer, and as a diagnostic agent in thyroid suppression tests. They are not for benign thyroid nodules or during subacute thyroiditis recovery.
    • synthroid

      (Levothyroxine Sodium)
      AbbVie Inc.
      Usage: SYNTHROID is indicated for replacement therapy in congenital or acquired hypothyroidism in patients of all ages. It is also used as an adjunct in managing well-differentiated thyroid cancer. It is not indicated for benign thyroid nodules or during recovery from subacute thyroiditis.
    • tirosint

      (levothyroxine sodium)
      IBSA Pharma Inc.
      Usage: TIROSINT is indicated for replacement therapy in adults and children aged 6 years and older with primary, secondary, or tertiary hypothyroidism. It is also used as an adjunct to surgery and radioiodine therapy for managing thyrotropin-dependent well-differentiated thyroid cancer in the same age group.
    • tirosint

      (Levothyroxine Sodium)
      IBSA Pharma Inc.
      Usage: TIROSINT-SOL is indicated for replacement therapy in congenital or acquired hypothyroidism in adults and pediatric patients. It is also used adjunctively in managing thyroid cancer requiring thyrotropin suppression. However, it should not be used for benign thyroid nodules or transient hypothyroidism during recovery from subacute thyroiditis.